Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06387069
What this trial is testing

Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hutchmed 316
Very early researchLooking for participantsNCT07336823
What this trial is testing

JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shenzhen Genocury Biotech Co., Ltd. 9
Not applicableUnknownNCT01344096
What this trial is testing

Thrombocytopathy in Gaucher Disease Patients

Who this might be right for
Gaucher DiseaseThrombocytopathy
Rabin Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT00982488
What this trial is testing

Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Bristol-Myers Squibb 238
Testing effectiveness (Phase 2)Looking for participantsNCT02877303
What this trial is testing

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT03267186
What this trial is testing

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Andrew Rezvani 8
Not applicableLooking for participantsNCT03312686
What this trial is testing

Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study

Who this might be right for
Eosinophilic Esophagitis
Indiana University 10
Testing effectiveness (Phase 2)Ended earlyNCT00006220
What this trial is testing

Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Washington University School of Medicine 5
Early research (Phase 1)Study completedNCT01098188
What this trial is testing

LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Laboratoire français de Fractionnement et de Biotechnologies 33
Testing effectiveness (Phase 2)Looking for participantsNCT07023588
What this trial is testing

Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease

Who this might be right for
Acute Myeloid Leukemia (AML)
Yehui Tan 70
Large-scale testing (Phase 3)Study completedNCT02242942
What this trial is testing

Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 445
Testing effectiveness (Phase 2)UnknownNCT05587088
What this trial is testing

Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)

Who this might be right for
Neoplasm, StomachGastric Neoplasms MalignantPancreatic Neoplasms+6 more
Hospital Universitario San Ignacio 82
Not applicableStudy completedNCT04091386
What this trial is testing

Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)

Who this might be right for
Hemophilia A
Bayer 10
Not applicableUnknownNCT04864041
What this trial is testing

Evaluation of Left Ventricular Function by Speckle Tracking Echocardiography in Patient Hospitalised in Intensive Care Unit for Vaso-occlusive Crisis

Who this might be right for
Sickle Cell Disease
Bicetre Hospital 30
Not applicableLooking for participantsNCT06357754
What this trial is testing

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic LeukaemiaMultiple Myeloma
Bristol-Myers Squibb 50
Testing effectiveness (Phase 2)Study completedNCT02213913
What this trial is testing

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Diffuse Large Cell Lymphoma+69 more
University of Chicago 55
Testing effectiveness (Phase 2)Study completedNCT00003960
What this trial is testing

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Testing effectiveness (Phase 2)Ended earlyNCT01174082
What this trial is testing

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 2
Early research (Phase 1)Temporarily pausedNCT06888323
What this trial is testing

Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment

Who this might be right for
Refractory Myelodysplastic Syndrome
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT01146223
What this trial is testing

Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)+1 more
Children's Oncology Group 10
Next Page